These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32771940)

  • 1. Volatile organic compounds in human matrices as lung cancer biomarkers: a systematic review.
    Janssens E; van Meerbeeck JP; Lamote K
    Crit Rev Oncol Hematol; 2020 Sep; 153():103037. PubMed ID: 32771940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
    Oakley-Girvan I; Davis SW
    Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
    Hua Q; Zhu Y; Liu H
    Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis.
    Zhou J; Huang ZA; Kumar U; Chen DDY
    Anal Chim Acta; 2017 Dec; 996():1-9. PubMed ID: 29137702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
    Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
    Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening.
    Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C
    Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VOC breath biomarkers in lung cancer.
    Saalberg Y; Wolff M
    Clin Chim Acta; 2016 Aug; 459():5-9. PubMed ID: 27221203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of volatile organic compounds as a diagnostic tool in preterm infants.
    Wright H; Bannaga AS; Iriarte R; Mahmoud M; Arasaradnam RP
    Pediatr Res; 2021 Jan; 89(2):263-268. PubMed ID: 32120380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
    Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
    J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment, origin, and implementation of breath volatile cancer markers.
    Haick H; Broza YY; Mochalski P; Ruzsanyi V; Amann A
    Chem Soc Rev; 2014 Mar; 43(5):1423-49. PubMed ID: 24305596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analyses of volatile organic compounds (VOCs) from patients, tumors and transformed cell lines for the validation of lung cancer-derived breath markers.
    Filipiak W; Filipiak A; Sponring A; Schmid T; Zelger B; Ager C; Klodzinska E; Denz H; Pizzini A; Lucciarini P; Jamnig H; Troppmair J; Amann A
    J Breath Res; 2014 Jun; 8(2):027111. PubMed ID: 24862102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
    Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
    Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of volatile organic compounds in lung cancer cell lines and lung cancer tissue].
    Hu YJ; Qiu YH; Chen EG; Ying KJ; Yu J; Wang P
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):278-84. PubMed ID: 20544990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemiresistive Sensor Array with Nanostructured Interfaces for Detection of Human Breaths with Simulated Lung Cancer Breath VOCs.
    Shang G; Dinh D; Mercer T; Yan S; Wang S; Malaei B; Luo J; Lu S; Zhong CJ
    ACS Sens; 2023 Mar; 8(3):1328-1338. PubMed ID: 36883832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the early detection of lung cancer using analysis of volatile organic compounds: from imaging to sensors.
    Li W; Liu HY; Jia ZR; Qiao PP; Pi XT; Chen J; Deng LH
    Asian Pac J Cancer Prev; 2014; 15(11):4377-84. PubMed ID: 24969857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
    Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
    PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
    Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
    Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
    Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
    Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
    J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.